• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Pfizer’s Hospira, Iatric Systems ink infusion pump interoperability deal

Pfizer’s Hospira, Iatric Systems ink infusion pump interoperability deal

December 19, 2016 By Fink Densford

Iatric Systems, HospiraPfizer (NYSE:PFE) said today that its Hospira subsidiary and healthcare IT group Iatric Systems inked a partnership deal to develop interoperability between Hospira’s smart infusion pumps and Iatric’s Accelero Connect integration software.

The 2 companies said they are currently piloting smart-pump EMR interoperability at an undisclosed US hospital.

“Hospira is proud to partner with Iatric Systems to make IV-EMR interoperability available to the hundreds of hospitals where Iatric Systems performs integration. After already becoming the first smart pump vendor to successfully integrate with three major EMR platforms, we are excited to add another major EMR system to the list once this pilot site goes live,” Hospira prez Julie Sawyer-Montgomery said in a press release

The project aims to provide 2-way communication between the system to enable pump programming automation with validated EMR medication orders, as well as documenting medication administrations into the patient’s EMR.

“Smart pump-EMR integration can help save lives and money. Simply put, it’s the right thing to do. On the clinical side, we’re sending IV medication orders from the EMR to the infusion pump, which significantly minimizes the chance of human errors and helps improve patient outcomes. On the financial side, we’re sending start times, stop times, and other infusion details from the pump back to the EMR, which saves nurses time and may improve hospital reimbursements. This is a win-win for everyone, and we’re proud to partner with Hospira in this advancement of patient care,” Iatric Systems pzrez Frank Fortner said in prepared remarks.

In October, ICU Medical (NSDQ:ICUI) said it agreed to pay $1 billion in cash and stock for the Hospira infusion pump business, confirming rumors that swirled earlier this year that the drug giant was looking to sell the business.

The deal calls for ICU Medical to put up $400 million worth of new shares and $600 million in cash, leaving Pfizer with a 16.6% stake in ICU. The acquisition, expected to close during the 1st quarter of 2017, includes IV pumps, solutions and devices made by the Hospira Infusion Systems business. ICU pegged its pro-forma annual revenues after the deal at roughly $1.45 billion, based on trailing 12-month results as of June.

Filed Under: Business/Financial News, Drug Pumps, Software / IT Tagged With: Hospira Inc., Iatric Systems

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy